The Zacks Analyst Blog Highlights: CME Group, Morgan Stanley, JP Morgan Chase, Goldman Sachs Group and Royal Dutch Shell plc - Press Releases
For Immediate Release
Chicago, IL - February 23, 2012 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include CME Group Inc. ( CME ), Morgan Stanley ( MS ), JP Morgan Chase & Co. ( JPM ), Goldman Sachs Group Inc. ( GS ) and Royal Dutch Shell plc ( RDS.A ).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Wednesday's Analyst Blog:
CME Hikes Stake in Dubai Mercantile
In an attempt to strengthen its oil futures market, yesterday, CME Group Inc. ( CME ) announced the acquisition of another 25% stake in the Dubai Mercantile Exchange (DME), thereby owning 50% of this Dubai's commodities exchange in total.
The DME was established as a joint venture (JV) between the Dubai and Omani governments and the New York Mercantile Exchange (NYMEX) in 2007. However, following the acquisition of NYMEX by CME, the latter got a one-fourth stake in the DME.
While CME doubled its stake in DME, the Oman Investment Fund had raised its ownership to 29%, leaving Dubai Holdings with a 9% stake. The remaining 12% of DME is owned in tidbits by firms such as Morgan Stanley ( MS ), JP Morgan Chase & Co. ( JPM ), Goldman Sachs Group Inc. ( GS ), Royal Dutch Shell plc ( RDS.A ), Concord Energy and Vitol. The shift of interest was part of the recapitalization process initiated by DME to restructure its debt.
Hiking its stake in DME appears to be a strategy growth step for CME, which has been firming its global footprint in the energy sphere for long now. Additionally, as CME has already been launching its crude oil futures and options contracts on the globally leading Brent and light sweet crude oil ( WTI ) benchmarks, initiating crude oil futures through DME would further enhance its reach in the rapidly developing markets of Middle East and Asia.
Moreover, DME being out of the Organization of the Petroleum Exporting Countries (OPEC) enjoys liberty of price discovery and is open to testing new risk management products. These factors pave scope for DME to stay ahead and quickly acclimatize to the consistent changes in global industry dynamics. DME also aims to grow as a benchmark for new crude oil futures contracts in Middle East and Asia, and price these contracts within the region as most of the crude oil is generated in the Middle East.
Hence, being a part of such an attractively positioned mercantile exchange could further prove to be a feather in CME's cap in the long run. Meanwhile, the company is head on heels to expand its market share by leaps and bounds. CME is also eyeing London Metal Exchange (LME) to enhance its metals exchange, Comex, and strengthen its competitive position in Europe. The company had participated in the preliminary bid to acquire LME, which closed last week.
Overall, we believe that CME's efforts to promote, expand and cross-sell its core exchange-traded business through strategic alliances, meaningful acquisitions, newer product initiatives along with its global presence will generate a decent growth in the long term.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515 .
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518 .
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
CME GROUP INC ( CME ): Free Stock Analysis Report
GOLDMAN SACHS ( GS ): Free Stock Analysis Report
JPMORGAN CHASE ( JPM ): Free Stock Analysis Report
MORGAN STANLEY ( MS ): Free Stock Analysis Report
ROYAL DTCH SH-A (RDS.A): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research